Altis Labs raises $25M series a

◆ Amount

$25M

◆ Announced

22 Sept 2026

◆ Company

◆ Source

◆ The Round

Altis Labs raised $25M in series a funding, announced on 22 September 2026, led by OrbiMed, Qiming Venture Partners USA. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Altis Labs

Toronto-based healthtech startup providing AI-powered prognosis platform for clinical oncology trials that detects treatment effects from radiology scans. Altis Labs is based in Canada and currently at series a stage, operating in Biotech, AI & ML.

◆ Investors

◆ Market context

This funding event is a citable node in Fusion42's market graph: it links Altis Labs's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market